Inspire Medical Systems/$INSP
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Ticker
$INSP
Sector
Primary listing
NYSE
Employees
1,246
Headquarters
Website
INSP Metrics
BasicAdvanced
$2.4B
56.78
$1.48
0.77
-
Price and volume
Market cap
$2.4B
Beta
0.77
52-week high
$216.01
52-week low
$70.77
Average daily volume
1.2M
Financial strength
Current ratio
5.291
Quick ratio
3.885
Long term debt to equity
4.547
Total debt to equity
4.888
Interest coverage (TTM)
992.62%
Profitability
EBITDA (TTM)
49.34
Gross margin (TTM)
84.92%
Net profit margin (TTM)
5.05%
Operating margin (TTM)
4.16%
Effective tax rate (TTM)
14.34%
Revenue per employee (TTM)
$710,000
Management effectiveness
Return on assets (TTM)
2.86%
Return on equity (TTM)
6.54%
Valuation
Price to earnings (TTM)
56.775
Price to revenue (TTM)
2.81
Price to book
3.65
Price to tangible book (TTM)
3.65
Price to free cash flow (TTM)
25.097
Free cash flow yield (TTM)
3.98%
Free cash flow per share (TTM)
3.339
Growth
Revenue change (TTM)
16.81%
Earnings per share change (TTM)
34.77%
3-year revenue growth (CAGR)
36.33%
3-year earnings per share growth (CAGR)
-6.77%
What the Analysts think about INSP
Analyst ratings (Buy, Hold, Sell) for Inspire Medical Systems stock.
INSP Financial Performance
Revenues and expenses
INSP Earnings Performance
Company profitability
INSP News
AllArticlesVideos
Rosen Law Firm Urges Inspire Medical Systems, Inc. (NYSE: INSP) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Business Wire7 hours ago
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Business Wire11 hours ago
Robbins Geller Rudman & Dowd LLP Announces a Class Action Lawsuit Has Been Filed Against Inspire Medical Systems, Inc. (INSP)
Business Wire12 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inspire Medical Systems stock?
Inspire Medical Systems (INSP) has a market cap of $2.4B as of November 08, 2025.
What is the P/E ratio for Inspire Medical Systems stock?
The price to earnings (P/E) ratio for Inspire Medical Systems (INSP) stock is 56.78 as of November 08, 2025.
Does Inspire Medical Systems stock pay dividends?
No, Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders as of November 08, 2025.
When is the next Inspire Medical Systems dividend payment date?
Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders.
What is the beta indicator for Inspire Medical Systems?
Inspire Medical Systems (INSP) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.